A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）

NCT07191431 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma Cns

Interventions

DRUG: Selinexor+Orelabrutinib+Methotrexate/Thiotepa/Temozolomide

Sponsor

Ruijin Hospital